Vir Biotechnology, Inc. Stock Agreements
9 Contracts & Agreements
- Stock Purchase Agreement between the Company and the Bill & Melinda Gates Foundation, dated January 12, 2022 (Filed With SEC on February 28, 2022)
- Stock Purchase Agreement between the Company and Glaxo Group Limited, dated February 14, 2021 (Filed With SEC on May 6, 2021)
- Stock Purchase Agreement between the Company and Glaxo Group Limited, dated April 5, 2020 (Filed With SEC on July 6, 2020)
- Amendment No. 1 to the Common Stock Issuance Agreement between the Company and Alnylam Pharmaceuticals, Inc., dated December 17, 2019 (Filed With SEC on March 26, 2020)
- Description of Capital Stock (Filed With SEC on March 26, 2020)
- 2019 Employee Stock Purchase Plan (Filed With SEC on September 30, 2019)
- Form of Common Stock Certificate of the Registrant (Filed With SEC on September 30, 2019)
- Common Stock Issuance Agreement between the Registrant and Alnylam Pharmaceuticals, Inc., dated October 16, 2017 (Filed With SEC on September 3, 2019)
- 2019 Employee Stock Purchase Plan (Filed With SEC on September 3, 2019)
